Skip to content

AURA

Aura Biosciences, Inc.

NASDAQ · USHealthcareBiotechnology
$6.82-2.43%

Price as of Jul 20, 2026

AURA capital

Aura Biosciences, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.16x
Net debt / equity
-0.63x
Debt / assets
0.12x
Debt / EBITDA
-0.15x
Net debt / EBITDA
0.61x

Liquidity & coverage

Current ratio
7.09x
Quick ratio
7.09x
Cash ratio
6.87x
Interest coverage
EBITDA / interest
Working capital
$101.8M

Cash & dividend

FCF / debt
-5.39x
Cash flow / debt
-5.37x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.